Systemic therapy for advanced uterine sarcoma: A systematic review of the literature
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (2) , 624-637
- https://doi.org/10.1016/j.ygyno.2005.01.041
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozoleGynecologic Oncology, 2004
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002
- Endometrial Stromal Sarcoma: Objective Response to LetrozoleGynecologic Oncology, 2001
- Evidence for a Common Etiology for Endometrial Carcinomas and Malignant Mixed Mullerian TumorsGynecologic Oncology, 1998
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993
- Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcomaBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Steroid Hormone Receptors in Endometrial Stromal Sarcomas: A Biochemical and Immunohistochemical StudyAmerican Journal of Clinical Pathology, 1992
- Uterine sarcoma: Steroid receptors and response to hormonal therapyGynecologic Oncology, 1990
- Endolymphatic stromal myosis: A case with positive estrogen and progesterone receptors and good response to progestinsGynecologic Oncology, 1985
- Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomyCancer, 1982